Admission Date:  [**2127-4-7**]              Discharge Date:   [**2127-4-19**]  Date of Birth:  [**2050-7-12**]             Sex:   F  Service: SURGERY  Allergies: lobster / Penicillins / Sulfa(Sulfonamide Antibiotics)  Attending:[**First Name3 (LF) 2836**] Chief Complaint: Pancreatic mass  Major Surgical or Invasive Procedure: Modified classical Whipple with portal vein reconstruction and placement of jejunostomy tube.
History of Present Illness: 76F presenting with recurrent pancreatitis.
She failed ERCP at OSH and then had repeat here ERCP at [**Hospital1 **] that showed a stricture with proximal dilation; she subsequently underwent a sphincterotomy and stent placement and at present denied abdominal pain.
Daughter [**Name2 (NI) 1022**] was contact[**Name (NI) **] during her hospitalization [**Telephone/Fax (1) 110800**].
Former JP drain site clean, dry, intact.
R PICC in place without erythema or induration.
Right PICC tip is in the lower SVC.
Brief Hospital Course: The patient was admitted to the General Surgical Service on [**2127-4-7**] for treatment of a duodenal stricture causing pancreatitis.
On [**2127-4-7**] the patient underwent a modified classical Whipple with portal vein reconstruction and placement of jejunostomy tube, which went well without complication (reader referred to the Operative Note for details).
She arrived on the floor NPO with an NG tube, on IV fluids, with a foley catheter and a JP drain in place, and epidural for pain control.
Post-operative pain was initially well controlled with the epidural which was converted to oral pain medication when tolerating clear liquids.
The NG tube was discontinued on POD#3, and the foley catheter discontinued on POD#4.
She was made NPO, tube feeds were stopped and KUB was not revealing.
She was slowly advanced to a regular diet, but with limited oral intake; TPN was continued, cycling at night, to supplement her nutrition.
Her J tube unfortunately became clogged and could not be opened up despite several interventions; thus tube feeds were temporarily held until reassessment at her follow-up appointment.
The patient received subcutaneous heparin and venodyne boots were used during this stay.
Medications on Admission: amlodipine 5', atenolol 25', ASA 81, protonix 40'   Discharge Medications: 1. pantoprazole 40 mg Tablet, Delayed Release (E.C.)
2. hydromorphone 2 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed for pain for 10 days.
Disp:*45 Tablet(s)* Refills:*0* 3. amlodipine 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
4. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
5. acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed for fever/pain.
6. metoclopramide 10 mg Tablet Sig: 0.5 Tablet PO QIDACHS (4 times a day (before meals and at bedtime)).
7. atenolol 25 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
8. heparin (porcine) 5,000 unit/mL Solution Sig: One (1) Injection TID (3 times a day).
ZOFRAN ODT 4 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, Rapid Dissolve PO every eight (8) hours as needed for nausea for 2 weeks.
10. insulin regular human 100 unit/mL Solution Sig: One (1) Injection ASDIR (AS DIRECTED).
11. glucagon (human recombinant) 1 mg Recon Soln Sig: One (1) Recon Soln Injection Q15MIN () as needed for hypoglycemia protocol.
Discharge Instructions: You were admitted to the [**Hospital1 18**] surgery service for surgical management of your pancreatic mass.
General Discharge Instructions: Please resume all regular home medications , unless specifically advised not to take a particular medication.
Also, please take any new medications as prescribed.
Avoid driving or operating heavy machinery while taking pain medications.
*You may shower, and wash surgical incisions with a mild soap and warm water.
You have a J tube in place which is currently clogged.
Your tube feeds have been suspended for now.
You will be continued on TPN until you are able to tolerate more PO intake.
This tube will be re-evaluated in clinic on [**2127-4-28**] when you see Dr. [**First Name (STitle) **].
